JP2019501879A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501879A5
JP2019501879A5 JP2018527221A JP2018527221A JP2019501879A5 JP 2019501879 A5 JP2019501879 A5 JP 2019501879A5 JP 2018527221 A JP2018527221 A JP 2018527221A JP 2018527221 A JP2018527221 A JP 2018527221A JP 2019501879 A5 JP2019501879 A5 JP 2019501879A5
Authority
JP
Japan
Prior art keywords
substituted
pharmaceutically acceptable
stereoisomer
cooh
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018527221A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019501879A (ja
JP6903658B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/078778 external-priority patent/WO2017089518A1/en
Publication of JP2019501879A publication Critical patent/JP2019501879A/ja
Publication of JP2019501879A5 publication Critical patent/JP2019501879A5/ja
Application granted granted Critical
Publication of JP6903658B2 publication Critical patent/JP6903658B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018527221A 2015-11-27 2016-11-25 インフルエンザウィルス感染に使用するための複素環インドール Active JP6903658B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15196811 2015-11-27
EP15196811.2 2015-11-27
PCT/EP2016/078778 WO2017089518A1 (en) 2015-11-27 2016-11-25 Heterocyclic indoles for use in influenza virus infection

Publications (3)

Publication Number Publication Date
JP2019501879A JP2019501879A (ja) 2019-01-24
JP2019501879A5 true JP2019501879A5 (US20040106767A1-20040603-C00005.png) 2021-05-13
JP6903658B2 JP6903658B2 (ja) 2021-07-14

Family

ID=54707665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018527221A Active JP6903658B2 (ja) 2015-11-27 2016-11-25 インフルエンザウィルス感染に使用するための複素環インドール

Country Status (16)

Country Link
US (1) US10626108B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP3380467B1 (US20040106767A1-20040603-C00005.png)
JP (1) JP6903658B2 (US20040106767A1-20040603-C00005.png)
KR (1) KR20180087290A (US20040106767A1-20040603-C00005.png)
CN (1) CN108290869B (US20040106767A1-20040603-C00005.png)
AU (1) AU2016359907B2 (US20040106767A1-20040603-C00005.png)
CA (1) CA3005514A1 (US20040106767A1-20040603-C00005.png)
DK (1) DK3380467T3 (US20040106767A1-20040603-C00005.png)
EA (1) EA201891278A1 (US20040106767A1-20040603-C00005.png)
ES (1) ES2882671T3 (US20040106767A1-20040603-C00005.png)
HR (1) HRP20211223T1 (US20040106767A1-20040603-C00005.png)
HU (1) HUE055200T2 (US20040106767A1-20040603-C00005.png)
LT (1) LT3380467T (US20040106767A1-20040603-C00005.png)
MA (1) MA43298A (US20040106767A1-20040603-C00005.png)
SI (1) SI3380467T1 (US20040106767A1-20040603-C00005.png)
WO (1) WO2017089518A1 (US20040106767A1-20040603-C00005.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101702609B1 (ko) 2009-06-17 2017-02-03 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2016183116A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Methods of preparing inhibitors of influenza viruses replication
EP3405466B1 (en) 2016-01-20 2020-11-18 Janssen Sciences Ireland Unlimited Company Aryl substituted pyrimidines for use in influenza virus infection
US10501444B2 (en) 2016-08-16 2019-12-10 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
US10647693B2 (en) 2016-08-30 2020-05-12 North & South Brother Pharmacy Investment Company Limited Inhibitors of influenza virus replication, application methods and uses thereof
JP7034162B2 (ja) 2016-12-15 2022-03-11 サンシャイン・レイク・ファーマ・カンパニー・リミテッド インフルエンザウイルス複製の阻害剤及びその使用
WO2018119395A1 (en) * 2016-12-23 2018-06-28 Aquinnah Pharmaceuticals, Inc. Compouns, compositions and methods of use
US11098042B2 (en) 2017-01-05 2021-08-24 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
WO2018157830A1 (en) 2017-03-02 2018-09-07 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008117151A (ru) 2005-09-30 2009-11-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Деазапурины, пригодные в качестве ингибиторов янус-киназ
EP2040546A4 (en) * 2006-06-22 2009-12-23 Merck & Co Inc TYROSINE KINASE INHIBITORS
CN105254637A (zh) 2007-02-08 2016-01-20 爱尔兰詹森科学公司 嘧啶取代的大环抑制剂
KR101702609B1 (ko) * 2009-06-17 2017-02-03 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
ES2602972T3 (es) 2010-09-08 2017-02-23 Glaxosmithkline Intellectual Property Development Limited Derivados de indazol para su uso en el tratamiento de infección por virus de la gripe
AU2011343642A1 (en) 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2012083122A1 (en) * 2010-12-16 2012-06-21 Vertex Pharmaceutical Incorporated Inhibitors of influenza viruses replication
SI3330257T1 (sl) 2011-04-08 2020-07-31 Janssen Sciences Ireland Unlimited Company Derivati pirimidina za zdravljenje virusnih okužb
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2013184985A1 (en) 2012-06-08 2013-12-12 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
LT2909195T (lt) 2012-10-16 2017-09-25 Janssen Sciences Ireland Uc Antivirusiniai rsv junginiai
KR102300861B1 (ko) 2013-02-21 2021-09-10 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
EP3405466B1 (en) 2016-01-20 2020-11-18 Janssen Sciences Ireland Unlimited Company Aryl substituted pyrimidines for use in influenza virus infection

Similar Documents

Publication Publication Date Title
JP2019501879A5 (US20040106767A1-20040603-C00005.png)
JP2017531619A5 (US20040106767A1-20040603-C00005.png)
JP2017523225A5 (US20040106767A1-20040603-C00005.png)
JP2019510034A5 (US20040106767A1-20040603-C00005.png)
JP2020507589A5 (US20040106767A1-20040603-C00005.png)
JP2019510027A5 (US20040106767A1-20040603-C00005.png)
JP2018515495A5 (US20040106767A1-20040603-C00005.png)
JP2019509276A5 (US20040106767A1-20040603-C00005.png)
JP2016525102A5 (US20040106767A1-20040603-C00005.png)
HRP20211223T1 (hr) Heterociklički indoli za upotrebu kod infekcije virusom influence
JP2014521688A5 (US20040106767A1-20040603-C00005.png)
JP2016530259A5 (US20040106767A1-20040603-C00005.png)
JP2019524883A5 (US20040106767A1-20040603-C00005.png)
JP2017531038A5 (US20040106767A1-20040603-C00005.png)
JP2018524390A5 (US20040106767A1-20040603-C00005.png)
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
JP2019504890A5 (US20040106767A1-20040603-C00005.png)
JP2019505529A5 (US20040106767A1-20040603-C00005.png)
JP2017517565A5 (US20040106767A1-20040603-C00005.png)
JP2019500387A5 (US20040106767A1-20040603-C00005.png)
JP2020532547A5 (US20040106767A1-20040603-C00005.png)
JP2019519616A5 (US20040106767A1-20040603-C00005.png)
JP2018527301A5 (ja) アジリジン含有dnaアルキル化剤
JP2016540742A5 (US20040106767A1-20040603-C00005.png)
JP2020512337A5 (US20040106767A1-20040603-C00005.png)